Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1–Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study To develop and validate nomograms for OS ...
Decades from now, when we fully understand the biologic basis for the clinical heterogeneity of prostate cancer, we will think of the current era as the Golden Age of Prostate Nomograms. Driven by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results